Provider file · no-commitment flat · on-record
Precision Telemed: the file as of August 17, 2026
Precision Telemed publishes the current field’s cleanest no-commitment architecture: compounded tirzepatide at $249.99/month, written flat from the 2 mg starter to the 15 mg maximum, month-to-month with pause-or-cancel-anytime language, physician consult and shipping included — and its compounding pharmacy named on the page (Rush Pharmacy, a licensed 503A). Captured 2026-08-17 from the provider’s own site. On the value board it computes to ~$149 per expected point — the first Lane-C ratio this site has called fair — and it now undercuts Henry’s re-verified $449 by $199/month in Henry’s own tier.
What the capture shows
Written dose-proofing (“your flat rate from your starter 2 mg dose all the way to the maximum clinical 15 mg dose”), a named 503A pharmacy, explicit anti-“penalty-for-success” framing, and month-to-month exit language — four of the transparency checklist’s heavyweight items visible before checkout. What keeps it off the under-$150 pages is arithmetic, not architecture: $3,000/year buys freedom, and freedom is worth what your circumstances say it is.
Open files
Independent checkout walk · semaglutide lane details · refund mechanics on partial months · BUD-to-shipment alignment.
Standing rules apply: compounded products are not FDA-approved; trial certificates belong to the brands; tier upgrades require the same audit the anchor passed, and corrections@ outranks this page with dated evidence. Field context: the cost index · tirzepatide value board · semaglutide value board.
Precision Telemed’s published pricing ↗ (plain reference link — not a partner)